JOHANNAH BLAKE: Open Payments
NPI 1609426261 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 31 payments from 7 companies in 2025. Trend: 2023 $743 · 2024 $909 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $177 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Bausch Health US, LLC | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, SPRAVATO, Auvelity, TRINTELLIX, COBENFY, APLENZIN.
Industry payments across AZ — which companies pay providers there.
